| 2024-12-09 | Variant classified as CFTR-RD-causing (low penetrance) on the basis of epidemiological data (in particular high frequency in the general population), the number and type of diagnosis for patients reported in CFTR-France and functional data |
Variant NM_000492.4:c.2991G>C
| Name | NM_000492.4:c.2991G>C |
| Protein name | NP_000483.3:p.(Leu997Phe) |
| Genomic name (hg19) | chr7:g.117250575G>C UCSC |
| Genomic name (hg38) | chr7:g.117610521G>C UCSC |
| #Exon/intron | exon 19 |
| Legacy Name | L997F |
| Class | disease-causing |
| Subclass | CFTR-RD-causing |
| WT sequence | ACATGTTTTCTTTGATCTTACAGTT G TTATTAATTGTGATTGGAGCTATAG |
| Mutant sequence | ACATGTTTTCTTTGATCTTACAGTT C TTATTAATTGTGATTGGAGCTATAG |
![]() |
![]() | dbSNP rs1800111 |
![]() | ![]() |
| Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
| Van Goor et al, 2014 | 23891399 | ✓ | ✓ | ✓ | |||
| Sosnay et al, 2013 | 23974870 | ✓ | ✓ | ||||
| LaRusch et al, 2014 | 25033378 | ✓ | ✓ | ✓ | |||
| Bergougnoux et al, 2015 | 25797027 | ✓ | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | yes | no | yes | no |
| TEZ-IVA | yes | no | yes | no |
| ELX-TEZ-IVA | yes | no | yes | no |
| VNZ-TEZ-DIVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
4 individuals carrying this variant are reported in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 126 |
|---|---|
| Asymptomatic compound heterozygote | 11 |
| CF | 4 |
| CFTR-RD | 98
|
| Fetal bowel anomalies | 1 |
| Pending | 2 |
| Pending (NBS) | 10 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Pancreatitis | 5453 | heterozygote | CF-causing- Undef |
| Pancreatitis | 2346 | heterozygote | CF-causing- Undef |
| Pancreatitis | 2483 | heterozygote | |
| Pancreatitis | 2486 | heterozygote | CFTR-RD-causing- Undef non-CF- Undef |
| Pancreatitis | 4918 | heterozygote | VUS3- Undef |
| Pancreatitis | 2748 | heterozygote | |
| Pancreatitis | 2785 | heterozygote | |
| Pancreatitis | 2786 | heterozygote | CF-causing - Trans |
| Pancreatitis | 2285 | heterozygote | |
| Pancreatitis | 2242 | heterozygote | VUS3- Undef |
| Pancreatitis | 5454 | heterozygote | CF-causing- Undef |
| Pancreatitis | 5455 | heterozygote | CF-causing- Undef |
| Pancreatitis | 5668 | heterozygote | CF-causing- Undef |
| Pancreatitis | 5700 | heterozygote | CFTR-RD-causing- Undef |
| Pancreatitis | 5870 | heterozygote | CFTR-RD-causing- Undef non-CF- Undef |
| Pancreatitis | 5879 | heterozygote | |
| Pancreatitis | 5894 | heterozygote | |
| Pancreatitis | 6429 | heterozygote | VUS3- Undef |
| Pancreatitis | 6550 | heterozygote | CF-causing- Undef VUS3- Undef |
| Pancreatitis | 2198 | heterozygote | CFTR-RD-causing- Undef |
| Pancreatitis | 3182 | heterozygote | CF-causing- Undef |
| Pancreatitis | 4318 | heterozygote | CFTR-RD-causing- Undef |
| Pancreatitis | 6541 | heterozygote | likely CFTR-RD- Undef |
| Pancreatitis | 5623 | heterozygote | VUS3 - Trans |
| Pancreatitis | 3312 | heterozygote | |
| Pancreatitis | 5010 | heterozygote | CFTR-RD-causing- Undef |
| Pancreatitis | 76 | heterozygote | CF-causing - Trans |
| Pancreatitis | 964 | heterozygote | |
| Pancreatitis | 1650 | heterozygote | CFTR-RD-causing- Undef |
| Pancreatitis | 4977 | heterozygote | CF-causing- Undef |
| Pancreatitis | 1836 | heterozygote | CF-causing- Undef |
| Pancreatitis | 5102 | heterozygote | |
| Pancreatitis | 5368 | heterozygote | varying clinical consequence- Undef |
| Pancreatitis | 5388 | heterozygote | |
| Pancreatitis | 5145 | heterozygote | CF-causing- Undef |
| Pancreatitis | 6204 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Pancreatitis | 5862 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Pancreatitis | 4926 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Pancreatitis | 5125 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Pending (NBS) | 2038 | heterozygote | CF-causing- Undef |
| Pending (NBS) | 6003 | heterozygote | CF-causing- Undef |
| Pending (NBS) | 6084 | heterozygote | CF-causing- Undef |
| Pending (NBS) | 6089 | heterozygote | |
| Pending (NBS) | 4666 | heterozygote | CF-causing - Trans |
| Pending (NBS) | 6017 | heterozygote | |
| Pending (NBS) | 4693 | heterozygote | CF-causing - Trans |
| Pending (NBS) | 4667 | heterozygote | CF-causing - Trans |
| Pending (NBS) | 352 | heterozygote | CF-causing - Trans |
| Pending (NBS) | 5183 | heterozygote | CF-causing - Trans VUS3- Undef |
| Bronchiectasis | 2367 | heterozygote | |
| Bronchiectasis | 4906 | heterozygote | CFTR-RD-causing - Trans |
| Bronchiectasis | 1985 | heterozygote | CF-causing- Undef |
| Bronchiectasis | 3213 | heterozygote | CF-causing - Cis varying clinical consequence - Trans |
| Bronchiectasis | 4613 | heterozygote | |
| Bronchiectasis | 560 | heterozygote | CF-causing- Undef |
| Bronchiectasis | 4726 | heterozygote | varying clinical consequence- Undef |
| Bronchiectasis | 4866 | heterozygote | CF-causing- Undef |
| Bronchiectasis | 5153 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Other | 2696 | heterozygote | varying clinical consequence- Undef |
| Other | 4664 | heterozygote | CF-causing- Undef |
| Other | 4582 | heterozygote | CF-causing- Undef |
| Other | 6467 | heterozygote | CF-causing- Undef |
| Other | 645 | heterozygote | CF-causing- Undef |
| Other | 4842 | heterozygote | VUS3 - Trans |
| Other | 5201 | heterozygote | CF-causing- Undef |
| CBAVD | 4905 | heterozygote | CF-causing- Undef |
| CBAVD | 4919 | heterozygote | CF-causing- Undef |
| CBAVD | 2689 | heterozygote | CF-causing- Undef |
| CBAVD | 5871 | heterozygote | CF-causing- Undef |
| CBAVD | 4586 | heterozygote | |
| CBAVD | 4589 | heterozygote | |
| CBAVD | 6465 | heterozygote | CF-causing- Undef |
| CBAVD | 3318 | heterozygote | CFTR-RD-causing - Trans non-CF - Trans |
| CBAVD | 3361 | heterozygote | CF-causing- Undef |
| CBAVD | 3366 | heterozygote | CF-causing- Undef |
| CBAVD | 3377 | heterozygote | CF-causing - Trans |
| CBAVD | 6454 | heterozygote | CFTR-RD-causing- Undef non-CF- Undef |
| CBAVD | 525 | heterozygote | CF-causing - Trans |
| CBAVD | 538 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 707 | heterozygote | |
| CBAVD | 736 | heterozygote | CF-causing- Undef |
| CBAVD | 849 | heterozygote | CF-causing- Undef |
| CBAVD | 513 | heterozygote | CF-causing - Trans |
| CBAVD | 510 | heterozygote | |
| CBAVD | 428 | heterozygote | CF-causing - Trans |
| CBAVD | 447 | heterozygote | CF-causing- Undef |
| CBAVD | 461 | heterozygote | CF-causing- Undef |
| CBAVD | 462 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
| CBAVD | 469 | heterozygote | CF-causing- Undef |
| CBAVD | 482 | heterozygote | |
| CBAVD | 483 | heterozygote | CF-causing- Undef |
| CBAVD | 489 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 981 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 5444 | heterozygote | CF-causing- Undef |
| CBAVD | 1464 | heterozygote | CFTR-RD-causing - Trans non-CF - Trans |
| CBAVD | 1487 | heterozygote | CF-causing- Undef |
| CBAVD | 1634 | heterozygote | CF-causing- Undef |
| CBAVD | 1655 | heterozygote | CF-causing- Undef |
| CBAVD | 1759 | heterozygote | CF-causing- Undef |
| CBAVD | 5819 | heterozygote | CF-causing- Undef |
| CBAVD | 1294 | heterozygote | VUS3- Undef |
| Asymptomatic compound heterozygote | 3235 | heterozygote | CFTR-RD-causing - Trans |
| Asymptomatic compound heterozygote | 4749 | heterozygote | CF-causing - Trans |
| Asymptomatic compound heterozygote | 6452 | heterozygote | CF-causing - Trans |
| Asymptomatic compound heterozygote | 558 | heterozygote | CF-causing - Trans |
| Asymptomatic compound heterozygote | 575 | heterozygote | CFTR-RD-causing - Trans |
| Asymptomatic compound heterozygote | 740 | heterozygote | CFTR-RD-causing - Trans |
| Asymptomatic compound heterozygote | 965 | heterozygote | |
| Asymptomatic compound heterozygote | 5222 | heterozygote | VUS3- Undef |
| Asymptomatic compound heterozygote | 4960 | heterozygote | |
| Asymptomatic compound heterozygote | 5815 | heterozygote | |
| Asymptomatic compound heterozygote | 739 | homozygote | c.2991G>C - p.(Leu997Phe) - Trans |
| Fetal bowel anomalies | 828 | heterozygote | CF-causing - Trans |
| Aquagenic palmoplantar keratoderma | 4827 | heterozygote | CF-causing- Undef |
| Aquagenic palmoplantar keratoderma | 6348 | heterozygote | varying clinical consequence - Trans |
| Aquagenic palmoplantar keratoderma | 5470 | heterozygote | VUS3- Undef |
| Aquagenic palmoplantar keratoderma | 6480 | heterozygote | VUS3- Undef |
| CF | 5993 | heterozygote | CF-causing - Trans |
| CF | 5026 | heterozygote | CF-causing - Trans |
| CF | 4790 | heterozygote | CF-causing- Undef |
| CF | 4962 | heterozygote | CF-causing - Trans |
| Pending | 1240 | heterozygote | |
| Pending | 4748 | heterozygote | CF-causing - Trans |
| CRS-NP | 5778 | heterozygote | VUS3- Undef |
| CRS-NP | 5338 | heterozygote | non-CF- Undef |
| CRS-NP | 5994 | heterozygote | CF-causing - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|